Abbott Falls After Cutting 2021 Profit Forecast as Testing Slows
(Bloomberg) -- Abbott Laboratories fell the most in seven months after warning that profits for the year would be lower than expected because of eroding demand for Covid-19 tests.
Full-year adjusted earnings from continuing operations will range from $4.30 to $4.50 a share, the health-care company said Tuesday. In January, the company forecast at least $5 a share. Abbott fell as much as 6.9% to $108.63 as of 11 a.m. in New York, their biggest intraday loss since Nov. 9.
Abbott had hoped to maintain Covid test sales with the release of BinaxNOW for over-the-counter sale and home use. But as U.S. vaccination rates grow, infections wane and pandemic restrictions loosen, use of the assays has declined. In April, U.S. health officials said fully vaccinated individuals don't need testing, though they were advised to continue wearing masks in certain circumstances and to avoid crowds.
“We've recently seen a rapid decline in Covid-19 testing demand and anticipate this trend will continue,” Robert Ford, Abbott's chief executive officer, said in a statement.
Predicting Covid-19 testing needs after a year spent rapidly expanding capacity has proven challenging for test makers and providers. Early this year, Laboratory Corp of America Holdings said that testing demand could decline by as much as half in 2021. Rival Quest Diagnostics Inc., meanwhile, in late April provided guidance only for the first half of the year, and the company's executives warned of declining virus testing demand in the latter part of the year.
Abbott benefited earlier in the pandemic from rising demand for Covid screening, but its shares have been falling of late, declining some 9% from a 52-week high reached on Feb. 12 through Friday's close.
Abbott expects continued growth in non-Covid diagnostics. Compared with the first quarter of 2019, the most relevant pre-pandemic benchmark, the company's base business grew nearly 10% organically in the first quarter of this year, Ford said on a call with investors.
“We expect this accelerating growth trend to continue over the remainder of the year,” he said.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.